Ignite Creation Date:
2024-05-06 @ 7:59 PM
Last Modification Date:
2024-10-26 @ 3:17 PM
Study NCT ID:
NCT06204991
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-01-12
First Post:
2023-12-15
Brief Title:
To Evaluate the Safety and Efficacy of ADP-TILIL7 in Patients With Locally Advanced or Metastatic Melanoma
Sponsor:
Inge Marie Svane
Organization:
Herlev Hospital
Organization Data
Organization:
Herlev Hospital
Class:
OTHER
Study ID:
MM2319
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Inge Marie Svane
Lead Sponsor Class:
OTHER
Responsible Party:
Inge Marie Svane
Responsible Party Title:
Professor MD PhD
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Herlev Hospital
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Adaptimmune | INDUSTRY |